Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial

BACKGROUND: Patients with diabetes mellitus (DM) are at increased risk of developing heart failure (HF). The “Heart OMics in AGEing” (HOMAGE) trial suggested that spironolactone had beneficial effect on fibrosis and cardiac remodelling in an at risk population, potentially slowing the progression to...

Descripción completa

Detalles Bibliográficos
Autores principales: Verdonschot, Job A. J., Ferreira, João Pedro, Pellicori, Pierpaolo, Brunner-La Rocca, Hans-Peter, Clark, Andrew L., Cosmi, Franco, Cuthbert, Joe, Girerd, Nicolas, Mariottoni, Beatrice, Petutschnigg, Johannes, Rossignol, Patrick, Cleland, John G. F., Zannad, Faiez, Heymans, Stephane R. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351439/
https://www.ncbi.nlm.nih.gov/pubmed/34372849
http://dx.doi.org/10.1186/s12933-021-01357-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351439/
https://www.ncbi.nlm.nih.gov/pubmed/34372849
http://dx.doi.org/10.1186/s12933-021-01357-9

Ejemplares similares